The In Vivo and In Vitro Effects of Terminalia bellirica (Gaertn.) Roxb. Fruit Extract on Testosterone-Induced Hair Loss
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Due to the continuous increase in patients with androgenetic alopecia (AGA) and psychological disorders such as depression and anxiety, the demand for hair loss treatment and effective hair growth materials has increased. Terminalia bellirica (Gaertn.) Roxb. (TBE) reportedly exerts antiinflammatory, hepatoprotective, and antidiabetic effects, among others, but its effects on testosterone (TS)-inhibited hair growth remains unclear. In this study, we evaluated the effects of TBE on TSinduced hair growth regression in human follicle dermal papilla cells (HFDPCs) and C57BL/6 mice. Oral administration of TBE increased TS-induced hair growth retardation. Interestingly, effects were greater when compared with finasteride, a commercial hair loss treatment product. Histological analyses revealed that oral TBE administration increased hair follicles in the dorsal skin of C57BL/6 mice. Additionally, western blotting and immunofluorescence showed that oral TBE administration recovered the TS-induced inhibition of cyclin D1, proliferating cell nuclear antigen (PCNA), and Ki67 expression in vivo. Using in vitro proliferation assays, TBE promoted HFDPC growth, which was suppressed by TS treatment. Thus, TBE may be a promising nutraceutical for hair health as it promoted hair growth in AGA-like in vitro and in vivo models.
Abstract
Due to the continuous increase in patients with androgenetic alopecia (AGA) and psychological disorders such as depression and anxiety, the demand for hair loss treatment and effective hair growth materials has increased. Terminalia bellirica (Gaertn.) Roxb. (TBE) reportedly exerts antiinflammatory, hepatoprotective, and antidiabetic effects, among others, but its effects on testosterone (TS)-inhibited hair growth remains unclear. In this study, we evaluated the effects of TBE on TSinduced hair growth regression in human follicle dermal papilla cells (HFDPCs) and C57BL/6 mice. Oral administration of TBE increased TS-induced hair growth retardation. Interestingly, effects were greater when compared with finasteride, a commercial hair loss treatment product. Histological analyses revealed that oral TBE administration increased hair follicles in the dorsal skin of C57BL/6 mice. Additionally, western blotting and immunofluorescence showed that oral TBE administration recovered the TS-induced inhibition of cyclin D1, proliferating cell nuclear antigen (PCNA), and Ki67 expression in vivo. Using in vitro proliferation assays, TBE promoted HFDPC growth, which was suppressed by TS treatment. Thus, TBE may be a promising nutraceutical for hair health as it promoted hair growth in AGA-like in vitro and in vivo models.
참고문헌 (32)
- Houschyar KS, "Molecular mechanisms of hair growth and regeneration: Current understanding and novel paradigms", Dermatology, 236, pp.271~280 (2020)
- Hardy MH, "The secret life of the hair follicle", Trends Genet, 8, pp.55~61 (1992)
- Wolfram LJ, "Human hair: a unique physicochemical composite", J. Am. Acad. Dermatol, 48, pp.S106~S114 (2003)
- Natarelli N, "Integrative and mechanistic approach to the hair growth cycle and hair loss", J. Clin. Med, 12, pp.893~ (2023)
- Alessandrini A, "Common causes of hair loss - clinical manifestations, trichoscopy and therapy", J. Eur. Acad. Dermatol. Venereol, 35, pp.629~640 (2021)
- Dhariwala MY, "An overview of herbal alternatives in androgenetic alopecia", J. Cosmet. Dermatol, 18, pp.966~975 (2019)
- Phillips TG, "Hair loss: Common causes and treatment", Am. Fam. Physician, 96, pp.371~378 (2017)
- Wang H, "Epidemiological trends in alopecia areata at the global, regional, and national levels", Front. Immunol, 13, pp.874677~ (2022)
- Aukerman EL, "The psychological consequences of androgenetic alopecia: a systematic review", J. Cosmet. Dermatol, 22, pp.89~95 (2023)
- Fu D, "Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia", Biomed. Pharmacother, 137, pp.111247~ (2021)
- Leirós GJ, "Androgens modify Wnt agonists", antagonists expression balance in dermal papilla cells preventing hair follicle stem cell differentiation in androgenetic alopecia, 2017, pp.439, 26~34
- Gentile P, "Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: Wnt pathway, growthfactor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development", Cells, 8, pp.466~ (2019)
- Nestor MS, "Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics", J. Cosmet. Dermatol, 20, pp.3759~3781 (2021)
- Gupta A, "Terminalia bellirica (Gaertn.) roxb. (Bahera) in health and disease: a systematic and comprehensive review", Phytomedicine, 77, pp.153278~ (2020)
- Tanaka M, "Terminalia bellirica (Gaertn.) Roxb. extract and gallic acid attenuate LPS-induced inflammation and oxidative stress via MAPK", NF-κB and Akt, Nrf2 pathways, pp.Oxid. Med. Cell Longev, 2018[DOI]
- Kuriakose J, "Terminalia bellirica (Gaertn.) Roxb. fruit mitigates CCl(4) induced oxidative stress and hepatotoxicity in rats", Biomed. Pharmacother, 93, pp.327~333 (2017)
- Suryavanshi SV, "Triphala churna-A traditional formulation in ayurveda mitigates diabetic neuropathy in rats", Front. Pharmacol, 12, pp.662000~ (2021)
- Ke J, "Erbium: YAG laser (2,940 nm) treatment stimulates hair growth through upregulating Wnt 10b and β-catenin expression in C57BL", 6 mice, 2015, pp.8, 20883~20889
- Inui S, "Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla", J. Dermatol. Sci, 61, pp.1~6 (2011)
- Sobecki M, "The cell proliferation antigen Ki-67 organises heterochromatin", Elife, 5, pp.e13722~ (2016)
- Müller-Röver S, "A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages", J. Invest. Dermatol, 117, pp.3~15 (2001)
- Elliott K, "Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses", J. Invest. Dermatol, 113, pp.873~875 (1999)
- Ring C, "Nutraceuticals for androgenetic alopecia", J. Clin. Aesthet. Dermatol, 15, pp.26~29 (2022)
- Abdin R, "Treatment of androgenetic alopecia using PRP to target dysregulated mechanisms and pathways", Front. Med (Lausanne), 9, pp.843127~ (2022)
- Hamilton JB, "Patterned loss of hair in man; types and incidence", Ann. NY Acad. Sci, 53, pp.708~728 (1951)
- Lee S, "Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis", Acta Derm. Venereol, 99, pp.12~17 (2019)
- Shin DW, "The molecular mechanism of natural products activating Wnt", β-catenin signaling pathway for improving hair loss, 2022, pp.12, 1856~
- Zhu HL, "Serenoa repens extracts promote hair regeneration and repair of hair loss mouse models by activating TGF-β and mitochondrial signaling pathway", Eur. Rev. Med. Pharmacol. Sci, 22, pp.4000~4008 (2018)
- Ellis T, "Overexpression of sonic hedgehog suppresses embryonic hair follicle morphogenesis", Dev. Biol, 263, pp.203~215 (2003)
- Choi BY, "Targeting Wnt", β-catenin pathway for developing therapies for hair loss, 2020, pp.21, 4915~
- Papukashvili D, "Perspectives on miRNAs targeting DKK1 for developing hair regeneration therapy", Cells, 10, pp.2957~ (2021)
- Lin GL, "Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation", J. Cell. Biochem, 112, pp.3491~3501 (2011)